Results 1 to 10 of about 131,813 (277)
Vaccination Strategies Against Hepatic Diseases: A Scoping Review [PDF]
VaccinesBackground/Objectives: Viral hepatitis remains a significant global cause of chronic liver disease, highlighting the importance of effective vaccination strategies. This review assesses recent evidence on vaccine safety and effectiveness.
Zahra Beyzaei +3 more
doaj +2 more sources
Economic evaluation of national immunization program vaccines in China: a systematic review [PDF]
Health Economics ReviewObjective This study aims to systematically review the published economic evaluations of vaccines included in China’s National Immunization Program (NIP), synthesise the current evidence base, and assess their cost-effectiveness.
Jiannan Sun +11 more
doaj +2 more sources
Journal of Travel Medicine, 1995 Hepatitis A is a self-limiting inflammation of the liver, which is caused by the hepatitis A virus. The infection is rare in industrialized countries but highly endemic in many developing countries. Until recently, only short-lived protection was possible using human immunoglobulin, but inactivated hepatitis A vaccines have now become available.
, D'Hondt, , Beecham
+11 more sources
Physicians Infrequently Adhere to Hepatitis Vaccination Guidelines for Chronic Liver Disease [PDF]
, 2013 Background and Goals:Hepatitis A (HAV) and hepatitis B (HBV) vaccination in patients with chronic liver disease is an accepted standard of care. We determined HAV and HBV vaccination rates in a tertiary care referral hepatology clinic and the impact of ...
A Wasley +27 more
core +29 more sources
Brazilian Protocol for Sexually Transmitted Infections 2020: viral hepatitis
Revista da Sociedade Brasileira de Medicina Tropical, 2021 This article discusses viral hepatitis, a theme addressed by the Clinical Protocol and Therapeutic Guidelines to Comprehensive Care for People with Sexually Transmitted Infections and, more precisely, by the Clinical Protocols and Therapeutic Guidelines ...
Geraldo Duarte +4 more
doaj +1 more source
HBV Vaccines: Advances and Development
Vaccines, 2023 Hepatitis B virus (HBV) infection is a global public health problem that is closely related to liver cirrhosis and hepatocellular carcinoma (HCC). The prevalence of acute and chronic HBV infection, liver cirrhosis, and HCC has significantly decreased as ...
Faisal Mahmood +9 more
doaj +1 more source
Human Vaccines & Immunotherapeutics, 2020 Hepatitis A is an important public health issue worldwide. Hepatitis A vaccine (HepA) was first licensed in 1992. Both inactivated HepA (HepA-I) and live attenuated HepA (HepA-L) are highly immunogenic and well tolerated, and immune protection postvaccination can persist for at least 20 y.
openaire +3 more sources
Memorias do Instituto Oswaldo Cruz, 2012 Age-related seroprevalence studies that have been conducted in Brazil have indicated a transition from a high to a medium endemicity of hepatitis A virus (HAV) infection in the population.
Claudia Lamarca Vitral +15 more
doaj +1 more source
Recent Advances in Protective Vaccines against Hepatitis Viruses: A Narrative Review
Viruses, 2023 Vaccination has been confirmed to be the safest and, sometimes, the only tool of defense against threats from infectious diseases. The successful history of vaccination is evident in the control of serious viral infections, such as smallpox and polio ...
Ashraf Elbahrawy +7 more
doaj +1 more source
Pediatric Discovery, 2023 Our aim is an achievement of a 100 percent vaccination rate without toxic vaccine effects. We did a comprehensive literature review on aluminum neurotoxicity and early neonatal hepatitis B vaccination.
Aleksandar Cirovic +3 more
doaj +1 more source